Pharma Marketing Network

Hear from Rx, OTC, medical device companies and leading industry associations about how to examine and minimize potential liability issues, prepare for the logistical aspects of a recall and evaluate whether to outsource the recall process.

Distinguish lawful off-label communication from illegal off-label promotion

In November, the FDA will host a 2-day public meeting on direct-to-consumer (DTC) promotion of regulated products, including prescription drugs. According to the September...

Featured Conference Forum on Disease Awareness and Patient Education for the Pharmaceutical Industry September 22 -...

Attend CBI's annual conference and gain insight from the regulatory, clinical, marketing, adverse events and Post-Marketing perspectives.  The program provides a unique forum in which you can network with industry executives and Phase IV teams who can share their valuable experiences with you.

This conference provides insights into the economic implications of poor disease management and patient non-compliance.

Implementing Best Practices Towards Successful Outsourcing

The Washington post published an editorial favoring legislation to shield drug companies from punitive damages in lawsuits like the those currently faced by Merck....

Roy Vagelos, Former Chairman and CEO of Merck, gave a keynote presentation at the Pharmaceutical Marketing Congress in Philadelphia this past Tuesday. His presentation...

Article SummariescDetailing: Addressing the Consumer Education GapSteve Smith, Editor-in-Chief of Medsite has reengineered his company's eDetailing line to create engaging interactions crafted around effective...